Tenofovir DF
Sponsors
National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), Gilead Sciences, Abbott, French National Agency for Research on AIDS and Viral Hepatitis
Conditions
Chronic Hepatitis BHBVHIV InfectionHIV InfectionsHIV SeronegativityHepatitis BLipodystrophyPregnancy
Phase 1
Phase 2
A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation
CompletedNCT00036452
End: 2006-01-31Updated: 2021-11-01
Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
CompletedNCT00038220
Start: 2000-07-31Target: 40Updated: 2006-07-27
Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
WithdrawnNCT00078182
Updated: 2016-12-14
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
CompletedNCT00307489
Start: 2006-03-31End: 2010-10-31Updated: 2011-11-01
A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)
CompletedNCT00507507
Start: 2007-09-30End: 2012-08-31Updated: 2015-07-17
Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue
CompletedNCT00647946
Start: 2003-02-28End: 2006-02-28Updated: 2008-06-30
Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan
CompletedNCT01334567
Start: 2010-08-31End: 2013-12-31Updated: 2014-03-04
Phase 3
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
CompletedNCT00043966
Start: 2002-07-31Target: 200Updated: 2006-07-27
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
CompletedNCT00115609
Start: 2006-01-31End: 2009-11-30Updated: 2011-12-22
Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
CompletedNCT00234910
Start: 2005-01-31End: 2008-06-30Updated: 2008-07-10
Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy
CompletedNCT00352053
Start: 2006-06-30End: 2013-12-31Updated: 2015-07-14
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
CompletedNCT00528957
Start: 2006-12-28End: 2017-08-16Updated: 2018-03-14
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
Active, not recruitingNCT01651403
Start: 2012-12-06End: 2027-07-01Updated: 2026-01-30
Phase 4
Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy
CompletedNCT02039362
Start: 2012-07-31End: 2016-07-31Updated: 2017-04-28
Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection
TerminatedNCT02479880
Start: 2015-07-03End: 2018-04-11Updated: 2019-05-20